Atlas Trials

Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection

Clinical trial NCT05410496 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05410496
Sponsor
Taichung Veterans General Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Safety IssuesChronic Hepatitis BTransplant Recipient
Start date
2021-06-22
Primary completion
2024-05-30
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.